C. Mijovic

1.0k total citations
44 papers, 838 citations indexed

About

C. Mijovic is a scholar working on Genetics, Immunology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, C. Mijovic has authored 44 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 24 papers in Immunology and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in C. Mijovic's work include Diabetes and associated disorders (30 papers), T-cell and B-cell Immunology (17 papers) and Pancreatic function and diabetes (15 papers). C. Mijovic is often cited by papers focused on Diabetes and associated disorders (30 papers), T-cell and B-cell Immunology (17 papers) and Pancreatic function and diabetes (15 papers). C. Mijovic collaborates with scholars based in United Kingdom, Hong Kong and China. C. Mijovic's co-authors include Anthony Barnett, A.R. Bradwell, David J.A. Jenkins, Jack Μ. Fletcher, John A. Todd, A H Barnett, K. H. Jacobs, Michelle A. Penny, M. A. Kelly and Clive S. Cockram and has published in prestigious journals such as Nature, Diabetologia and Clinical Endocrinology.

In The Last Decade

C. Mijovic

44 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Mijovic United Kingdom 16 609 363 321 317 90 44 838
Antti‐Pekka Laine Finland 16 528 0.9× 397 1.1× 122 0.4× 414 1.3× 71 0.8× 25 681
Yasuhiko Kanazawa Japan 12 395 0.6× 271 0.7× 164 0.5× 216 0.7× 141 1.6× 23 582
Yoshikuni Sawai Japan 8 352 0.6× 209 0.6× 336 1.0× 74 0.2× 75 0.8× 17 640
Petros Vafiadis Canada 8 706 1.2× 425 1.2× 284 0.9× 474 1.5× 189 2.1× 8 992
Sung-Hong Joe South Korea 4 432 0.7× 192 0.5× 247 0.8× 221 0.7× 68 0.8× 8 603
Sunanda Babu United States 26 1.5k 2.4× 969 2.7× 513 1.6× 1.0k 3.2× 146 1.6× 51 1.9k
Anne Grethe Myhre Norway 11 472 0.8× 612 1.7× 150 0.5× 183 0.6× 108 1.2× 14 911
Theresa A. Aly United States 12 388 0.6× 243 0.7× 179 0.6× 287 0.9× 48 0.5× 14 543
S. Lesage France 4 313 0.5× 166 0.5× 57 0.2× 385 1.2× 263 2.9× 7 595
Petra Dušátková Czechia 17 509 0.8× 384 1.1× 69 0.2× 430 1.4× 314 3.5× 60 817

Countries citing papers authored by C. Mijovic

Since Specialization
Citations

This map shows the geographic impact of C. Mijovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Mijovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Mijovic more than expected).

Fields of papers citing papers by C. Mijovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Mijovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Mijovic. The network helps show where C. Mijovic may publish in the future.

Co-authorship network of co-authors of C. Mijovic

This figure shows the co-authorship network connecting the top 25 collaborators of C. Mijovic. A scholar is included among the top collaborators of C. Mijovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Mijovic. C. Mijovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kelly, M. A., et al.. (2002). Long‐Term Expression of an HLA‐DQ Molecule in the EBV‐Transformed Bare Lymphocyte Cell Line, BLS‐1, using a Plasmid Vector. Scandinavian Journal of Immunology. 55(6). 599–605. 2 indexed citations
2.
Hermann, Róbert, C. Mijovic, M. A. Kelly, et al.. (2001). HLA alleles and IDDM in children in Hungary: a comparison with Finland. Human Immunology. 62(4). 391–398. 13 indexed citations
3.
Kelly, M. A., Juliana C.N. Chan, J. M. Heward, et al.. (2001). HLA typing and immunological characterization of young‐onset diabetes mellitus in a Hong Kong Chinese population. Diabetic Medicine. 18(1). 22–28. 9 indexed citations
4.
Ng, Maggie, Ming Wai Yeung, C. C. Chow, et al.. (2000). Mitochondrial DNA A3243G mutation in patients with early‐ or late‐onset type 2 diabetes mellitus in Hong Kong Chinese. Clinical Endocrinology. 52(5). 557–564. 27 indexed citations
5.
McTernan, C. L., et al.. (2000). Assessment of the non‐HLA‐DR‐DQ contribution to IDDM1 in British Caucasian families: analysis of LMP7 polymorphisms. Diabetic Medicine. 17(9). 661–666. 4 indexed citations
6.
Chowdhury, Tahseen A, Philip Dyer, C. Mijovic, et al.. (1999). Human leucocyte antigen and insulin gene regions and nephropathy in Type I diabetes. Diabetologia. 42(8). 1017–1020. 10 indexed citations
8.
Mijovic, C., et al.. (1998). A novel PCR‐based methodology to determine TAP allele frequencies in population studies. Tissue Antigens. 52(1). 88–91. 5 indexed citations
9.
Mijovic, C., Michelle A. Penny, David J.A. Jenkins, et al.. (1997). The Insulin Gene Region and Susceptibility to Insulin-Dependent Diabetes Mellitus in Four Races; New Insights from Afro-Caribbean Race-Specific Haplotypes. Autoimmunity. 26(1). 11–22. 7 indexed citations
10.
Kelly, M. A., K. H. Jacobs, Michelle A. Penny, et al.. (1995). An investigation of HLA‐encoded genetic susceptibility to multiple sclerosis in subjects of Asian Indian and Afro‐Caribbean ethnic origin. Tissue Antigens. 45(3). 197–202. 25 indexed citations
11.
Kelly, M. A., et al.. (1995). Genetic susceptibility to multiple sclerosis in the Shanghai Chinese is not linked to the myelin basic protein gene microsatellite. Molecular Pathology. 48(2). M111–M112. 2 indexed citations
12.
Cavan, David, K. H. Jacobs, Michelle A. Penny, et al.. (1993). Both DQA1 and DQB1 genes are implicated in HLA-associated protection from type 1 (insulin-dependent) diabetes mellitus in a British Caucasian population. Diabetologia. 36(3). 252–257. 30 indexed citations
13.
Jacobs, K. H., David J.A. Jenkins, C. Mijovic, et al.. (1992). An investigation of Japanese subjects maps susceptibility to type 1 (insulin-dependent) diabetes mellitus close to the DQA1 gene. Human Immunology. 33(1). 24–28. 19 indexed citations
14.
Jenkins, David J.A., C. Mijovic, K. H. Jacobs, et al.. (1991). Allele-specific gene probing supports the DQ molecule as a determinant of inherited susceptibility to Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 34(2). 109–113. 30 indexed citations
15.
Mijovic, C., David J.A. Jenkins, J. Fletcher, et al.. (1989). RACE-SPECIFIC DR-DQ HAPLOTYPES ALLOW FINER MAPPING OF GENETIC SUSCEPTIBILITY TO TYPE-1 (INSULIN-DEPENDENT) DIABETES. Diabetologia. 32. 3 indexed citations
16.
Todd, John A., C. Mijovic, Jack Μ. Fletcher, et al.. (1989). Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature. 338(6216). 587–589. 204 indexed citations
17.
Fletcher, Jack Μ., et al.. (1988). Trans-racial studies implicate HLA-DQ as a component of genetic susceptibility to Type 1 (insulin-dependent) diabetes. Diabetologia. 31(12). 864–70. 43 indexed citations
18.
Mijovic, C., J. Fletcher, A.R. Bradwell, & A H Barnett. (1986). Phenotypes of the heavy chains of immunoglobulins in patients with diabetic microangiopathy: evidence for an immunogenetic predisposition.. BMJ. 292(6518). 433–435. 19 indexed citations
19.
Mijovic, C., J. Fletcher, A.R. Bradwell, Tim Harvey, & A H Barnett. (1985). Relation of gene expression (allotypes) of the fourth component of complement to insulin dependent diabetes and its microangiopathic complications.. BMJ. 291(6487). 9–10. 22 indexed citations
20.
Barnett, A H, C. Mijovic, J. Fletcher, et al.. (1984). Low plasma C4 concentrations: association with microangiopathy in insulin dependent diabetes.. BMJ. 289(6450). 943–945. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026